The identification of novel metabolites and the characterization of their biological functions are major challenges in biology. X-ray crystallography can reveal unanticipated ligands that persist through purification and crystallization. These adventitious protein-ligand complexes provide insights into new activities, pathways and regulatory mechanisms. We describe a new metabolite, carboxy-Sadenosyl-L-methionine (Cx-SAM), its biosynthetic pathway and its role in transfer RNA modification. The structure of CmoA, a member of the SAM-dependent methyltransferase superfamily, revealed a ligand consistent with Cx-SAM in the catalytic site. Mechanistic analyses showed an unprecedented role for prephenate as the carboxyl donor and the involvement of a unique ylide intermediate as the carboxyl acceptor in the CmoA-mediated conversion of SAM to Cx-SAM. A second member of the SAM-dependent methyltransferase superfamily, CmoB, recognizes Cx-SAM and acts as a carboxymethyltransferase to convert 5-hydroxyuridine into 5-oxyacetyl uridine at the wobble position of multiple tRNAs in Gram-negative bacteria 1 , resulting in expanded codon-recognition properties 2,3 . CmoA and CmoB represent the first documented synthase and transferase for Cx-SAM. These findings reveal new functional diversity in the SAM-dependent methyltransferase superfamily and expand the metabolic and biological contributions of SAM-based biochemistry. These discoveries highlight the value of structural genomics approaches in identifying ligands within the context of their physiologically relevant macromolecular binding partners, and in revealing their functions.
The identification of novel metabolites and the characterization of their biological functions are major challenges in biology. X-ray crystallography can reveal unanticipated ligands that persist through purification and crystallization. These adventitious protein-ligand complexes provide insights into new activities, pathways and regulatory mechanisms. We describe a new metabolite, carboxy-Sadenosyl-L-methionine (Cx-SAM), its biosynthetic pathway and its role in transfer RNA modification. The structure of CmoA, a member of the SAM-dependent methyltransferase superfamily, revealed a ligand consistent with Cx-SAM in the catalytic site. Mechanistic analyses showed an unprecedented role for prephenate as the carboxyl donor and the involvement of a unique ylide intermediate as the carboxyl acceptor in the CmoA-mediated conversion of SAM to Cx-SAM. A second member of the SAM-dependent methyltransferase superfamily, CmoB, recognizes Cx-SAM and acts as a carboxymethyltransferase to convert 5-hydroxyuridine into 5-oxyacetyl uridine at the wobble position of multiple tRNAs in Gram-negative bacteria 1 , resulting in expanded codon-recognition properties 2, 3 . CmoA and CmoB represent the first documented synthase and transferase for Cx-SAM. These findings reveal new functional diversity in the SAM-dependent methyltransferase superfamily and expand the metabolic and biological contributions of SAM-based biochemistry. These discoveries highlight the value of structural genomics approaches in identifying ligands within the context of their physiologically relevant macromolecular binding partners, and in revealing their functions.
Transfer RNAs contain many post-transcriptional modifications; nearly 100 distinct modifications have been reported 1 . Nucleotides at the wobble position (that is, the 59 nucleotide of the anticodon triplet) are the most frequent targets for such modifications, as they confer efficient and accurate pairing between anticodons and cognate codon sequences. For example, wobble uridines in Gram-negative bacteria are often modified at C5 to 5-oxyacetyl uridine (cmo5U) (Fig. 1a) , which enables multiple tRNAs to decode four of their respective degenerate codons 3 . This expanded recognition results from structural and tautomeric constraints imposed by the 5-oxyacetyl modification 4 .
Mutagenesis studies established that genes responsible for chorismate biosynthesis are necessary for cmo5U formation and it was shown that one carbon atom of the oxyacetyl group originates from SAM 5, 6 . Gene-disruption studies established that two members of the SAM-dependent methyltransferase superfamily (SDMT), CmoA and CmoB, were required for cmo5U formation 2 . Inactivation of cmoA resulted in formation of incompletely modified tRNAs, and hydroxy uridine (ho5U) and methoxy uridine (mo5U) were observed instead of cmo5U. In cmoB-defective mutants, only ho5U was detected. Despite these observations, the roles of CmoA and CmoB in the transformation of ho5U to cmo5U remain unclear. Wobble uridine hydroxylation is dependent on an unidentified enzyme ( Fig. 1a ).
As part of ongoing high-throughput efforts, the New York Structural Genomics Research Consortium (NYSGRC) determined the structure of Escherichia coli CmoA, which revealed unexpected electron-density features at the predicted SAM binding site. When SAM was modelled, residual electron density suggestive of a carboxylate group was observed adjacent to the S-methyl group. Refinement of this structure at 1.50 ångström (Å ) supports the idea that there is a covalent link between the S-methyl group and the putative carboxylate, consistent with the metabolite carboxy-SAM (Cx-SAM; (2S)-4-[{[(2S,3S,4R,5R)-5-(6amino-9H-purin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl}(carboxylatomethyl)sulfonio]-2-ammoniobutanoate), which was unknown previously ( Fig. 2 and Supplementary Fig. 1 ). Liquid chromatographymass spectrometry (LC-MS) analysis of purified CmoA, confirmed Cx-SAM as the CmoA-bound ligand that persisted through purification and crystallization ( Fig. 3 and Supplementary Fig. 2 ).
The overall structure of E. coli CmoA is similar to that previously reported for the Haemophilus influenzae orthologue (67% sequence identity; PDB entry 1IM8; root-mean-square deviation of 0.51Å for 222 equivalent C a atoms) 7 . Retrospective refinement of the H. influenza CmoA structure revealed electron-density features consistent with Cx-SAM and contacts similar to those observed in the E. coli enzyme. These observations support the existence of conserved pathways involving Cx-SAM in the Gram-negative bacteria.
The S-carboxymethyl group of Cx-SAM in the E. coli CmoA catalytic site forms a bidentate polar interaction with the side-chain guanidinium of Arg 199, which is invariant among CmoA orthologues. The 29-and 39hydroxyl groups of Cx-SAM form hydrogen bonds with the side chain of Asp 89; the equivalent residue in all other SAM-dependent methyltransferases is aspartate or glutamate. Other highly conserved residues among CmoA orthologues are contributed from helices a1, a6 and a7 (Supplementary Fig. 3 ), which seem to be crucial for substrate binding and are not present in other members of the SDMT superfamily. The Cx-SAM binding pocket is mainly hydrophobic, with no functionality capable of deprotonating the S-methyl group of SAM closer than 4.6 Å . Adjacent to the Cx-SAM binding site is a partially hydrophobic cavity, which is likely to be the binding site for an additional ligand or substrate (see below).
As there are data implicating chorismate, or a related metabolite, in wobble uridine oxyacetylation in Gram-negative bacteria 5,6 , chorismate was examined as the potential carboxyl donor. Chorismate supported the CmoA-mediated formation of Cx-SAM, as demonstrated using LC-MS ( Fig. 3b ) and MS/MS ( Supplementary Fig. 4 ). In addition to Cx-SAM, phenylpyruvate was produced with similar kinetics ( Fig. 3c and Supplementary Fig. 5 ). The lack of a facile pathway for the direct conversion of chorismate to phenylpyruvate suggested that chorismate undergoes a rearrangement before CmoA-catalysed Cx-SAM formation. Among the several biologically characterized products of chorismate, only prephenate possesses a scaffold consistent with the observed LC-MS and MS/MS fragmentation data.
When the in vitro production of Cx-SAM was investigated, prephenate was found to be a more efficient substrate than chorismate ( Fig. 3d ) and the lag in Cx-SAM production observed with chorismate was absent. This behaviour is consistent with the slow non-enzymatic conversion of chorismate to prephenate, which is used by CmoA for Cx-SAM formation ( Supplementary Fig. 6 ). Furthermore, production of phenylpyruvate from prephenate was confirmed by NMR and LC-MS of the in vitro assay solution ( Supplementary Figs 7 and 8 ). These activities are CmoA-specific as CmoB does not show any Cx-SAM synthase activity (data not shown). We propose that prephenate is the biologically relevant substrate and the source of the carboxylate in the CmoA-catalysed reaction.
These results are consistent with the CmoA-catalysed decarboxylation and concomitant loss of hydroxide from prephenate to produce phenylpyruvate, water and carbon dioxide, which is the source of the carboxylate functionality in Cx-SAM ( Fig. 1b ). In support of this hypothesis, uniformly 13 C-labelled chorismate ([U-13 C] chorismate) transferred 13 C-carbon dioxide to the product, Cx-SAM (Supplementary Fig. 9 ), demonstrating that prephenate is the carboxyl donor in the CmoA-catalysed formation of Cx-SAM and validating the overall reaction proposed for CmoA. To our knowledge, this is the first example of prephenate serving as the carboxyl group donor in a carboxytransfer reaction.
There is precedence for decarboxylation of prephenate, as prephenate dehydratase (PDT) catalyses the decarboxylation of prephenate with concomitant loss of hydroxide to generate phenylpyruvate in a fashion similar to that suggested for CmoA 8 . In the Methanocaldococcus jannaschii PDT-catalysed reaction, elimination of the hydroxyl group as water is facilitated by the participation of Thr 172 as a general acid to protonate the leaving hydroxide group. The threonine side chain is not sufficiently acidic to protonate the prephenate hydroxyl directly (that is, the conjugate acid of the prephenate hydroxyl is expected to behave in a similar manner to an alcohol, with a pK a of approximately 22, whereas the pK a of threonine is approximately 16 in water); thus, other mechanisms must be operative as the major driving force for this reaction. It was proposed previously that geometric distortion drives decarboxylation and that the favourable energetics associated with aromatization reduce the bond order of the hydroxyl, shifting its reactivity towards that of hydroxide and enabling efficient general acid catalysis 8 . Similar considerations are relevant to the CmoA-catalysed reaction.
Computational docking of prephenate in the CmoA catalytic site suggests a pose in which the carboxylate and hydroxyl groups of prephenate sandwich the S-methyl group of SAM, consistent with the observed transcarboxylation reaction ( Fig. 2 and Supplementary  Fig. 10 ). The importance of carbon-oxygen (CH … O) hydrogen bonds in the recognition and presentation of the S-methyl group in canonical mechanism for the biosynthesis of cmo5U. a, Previously identified biosynthetic pathway for cmo5U at wobble uridines. First, the wobble uridine is converted to ho5U by an unknown mechanism, and this is followed by the action of CmoA and CmoB. b, Mechanism for CmoAcatalysed Cx-SAM formation from SAM and prephenate. c, Mechanism for CmoB-catalysed formation of cmo5U from ho5U and Cx-SAM. 
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S N 2-based SAM-dependent methyltransfer reactions was highlighted recently 9 . In the prephenate-bound model of CmoA ( Fig. 2 and Supplementary Fig. 10 ), the hydroxyl oxygen of prephenate and the S-methyl carbon of SAM form a potential 3.4-Å CH … O hydrogen bond. Notably, the prephenate hydroxyl is poorly positioned for an in-line S N 2 attack on the S-methyl group, consistent with the lack of prephenate methylation. Instead, this arrangement suggests a substrate-assisted mechanism in which the departing prephenate OH group abstracts a proton from the S-methyl group of SAM, generating water and the nucleophilic ylide (stabilized carbanion), which is carboxylated by the carbon dioxide ( Fig. 1b) . Importantly, the pK a of the trimethylsulphonium cation (a model of the S-methyl group in SAM) has been reported as 18.9 and 18.2 in water and dimethylsulphoxide (DMSO) 10,11 , respectively. These values are similar to that of the general acid (Thr 172) in the PDT-catalysed reaction and are consistent with elimination of hydroxide from prephenate as water and formation of the reactive ylide intermediate. We sought direct evidence for the formation of the sulphonium ylide, given its importance in the mechanism. Presentation of CmoA with triply deuterated SAM ([ 2 H 3 -methyl]-SAM) and prephenate results in formation of doubly deuterated SAM, consistent with formation of the ylide intermediate by deuteron abstraction and regeneration of SAM by protonation ( Fig. 3f ). In the absence of prephenate, only triply deuterated SAM was observed. In the absence of CmoA, no exchange was observed in mixtures of [ 2 H 3 -methyl]-SAM and prephenate. Partitioning of the ylide between product formation (Cx-SAM) and its return to substrate (SAM) was quantified by determining the ratio between solvent-exchanged SAM and Cx-SAM: 92.0:8.0 and 97.3:2.7 at pH 7.3 and 8.5, respectively, providing strong evidence that the postulated ylide intermediate is on the reaction coordinate for Cx-SAM formation.
The most common biological fate of the SAM S-methyl group is intermolecular transfer catalysed by methyltransferases, including epigenetic marking of DNA and histone targets 12, 13 , and a wide range of small molecule transformations 14, 15 . We proposed that Cx-SAM is used in a CmoB-catalysed transcarboxymethylation reaction in the biosynthesis of cmo5U. Total RNA 16 and purified tRNAs 2 from cmoB-deficient cells (that is, ho5U-containing RNA) were used as substrates in in vitro assays with prephenate, SAM and CmoA, with or without recombinant CmoB. After the transfer reaction, RNAs were treated with P1 nuclease and the resulting 59-nucleotide monophosphates analysed by mass spectrometry (Fig. 4 ). CmoB catalysed carboxymethyl transfer from in situ-generated Cx-SAM to ho5U-containing RNAs, as a species with mass corresponding to oxyacetyl-5-uridine-59monophosphate (cmo5UMP) was clearly detected. CmoA alone does not exhibit carboxymethyltransferase activity. Therefore, we conclude that Cx-SAM is the substrate for the CmoB-dependent transcarboxymethylation of ho5U-containing tRNAs (Fig. 1c) .
In most Gram-negative species, cmoA and cmoB are co-conserved and immediately adjacent to each other in the genome, supporting the demonstrated functional relationship. Most importantly, the unique in vitro activities assigned to CmoA and CmoB are fully consistent with all reported genetics findings relevant to cmo5U modification 2,5,6 . Our own genetics and mutagenesis studies add further support, as plasmidbased expression of wild-type CmoA restores production of cmo5U in CmoA-deficient (DcmoA) E. coli, whereas the Asp89Leu mutant Total RNA extracted from CmoB mutant cells was used as a substrate, and Cx-SAM was generated in situ by the action of CmoA on prephenate and SAM. RNA was digested with P1 nuclease to 59-nucleotide monophosphates and then mass-spectrometry analysis was carried out. Left, no CmoB was added; right, addition of purified E. coli CmoB resulted in the detection of cmoUMP (C 11 H 14 O 12 N 2 P, m/z 5 397.0282 observed, 397.0284 calculated) in negative ion mode.
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lacking in vitro biochemical activity failed to complement in vivo ( Supplementary Fig. 11 ). Finally, in vivo-and in vitro-generated Cx-SAM-bound CmoA exhibited comparable behaviour in the carboxymethylation of ho5U-containing RNAs, supporting the relevance of our in vitro studies (see Supplementary Fig. 12 ).
Elaboration of the S-methyl group of SAM with a variety of functional groups has been pursued by chemical biologists to support studies including the generation of modified nucleic acid 17, 18 and protein 19 substrates, as well as genome-wide assignments of protein methyltransferase targets 19 . It is notable that Cx-SAM represents the first SAM derivative demonstrated to have been shaped by evolution for a biologically meaningful function. The electrophilic properties of the SAM sulphonium centre have been exploited to realize expanded functional diversity, as exemplified by Cx-SAM, through two unique activities within the SDMT superfamily ( Supplementary Fig. 13a ). Sequence analysis supports the existence of CmoA orthologues throughout the Gram-negative proteobacteria, as well as in the Verrucomicrobia and some Cyanobacteria ( Supplementary Fig. 13b ). It remains to be discovered how widespread these mechanisms are and whether additional biologically relevant SAM-analogues exist.
The fortuitous identification of a bound ligand in a crystal structure (such as Cx-SAM in CmoA) is not unusual. We estimate that approximately 3 to 5% of all structures determined by the NYSGRC contain organic ligands derived from the expression host (typically E. coli) that persisted through purification and crystallization. Frequently this can be anticipated; for example, finding NAD or NADH bound to targets annotated as oxidoreductases, or pyridoxal phosphate in annotated aminotransferases. However, unanticipated ligands are also identified, including nucleotides, amino acids, carbohydrates and lipids bound to proteins from a range of bacterial species, providing clues to catalytic activity and biological function (see examples in Supplementary Fig. 14) .
In summary, direct structural observation identified the novel metabolite Cx-SAM, leading to the discovery of unique Cx-SAM synthase and carboxymethyltransferase activities involved in tRNA wobble base modification. These findings reveal new functional diversity in the SDMT superfamily, expand the metabolic and biological contributions for SAM-based biochemistry, and presage the discovery of new metabolites and biological processes. This work highlights the power of structural genomics approaches for the discovery of new metabolites, pathways and biology.
METHODS SUMMARY
CmoA and CmoB were expressed in E. coli and purified by Ni-NTA (nickelnitriloacetic acid) and size-exclusion chromatography. CmoA was crystallized by vapour diffusion and the structure was determined by molecular replacement. CmoA-catalysed formation of carboxyl-SAM was monitored using [ 14 C-methyl]-SAM and either chorismate or prephenate as the carboxyl donor. Phenylpyruvate formation was monitored spectroscopically at 320 nm and ylide formation was monitored by solvent isotope exchange of trideuterated-SAM ([ 2 H 3 -methyl]-SAM). CmoB carboxymethyltransferase activity was assessed by the modification of RNAs purified from CmoB-deficient E. coli. Assay products were assigned by LC-MS, mass-spectrometry fragmentation and nuclear magnetic resonance (NMR).
METHODS
Cloning and protein purification. The cmoA gene was amplified from genomic DNA of E. coli BL21 by polymerase chain reaction (PCR), cloned into LIC-pET46a (Novagen) and verified by the DNA sequence analysis (Genewiz). E. coli BL21 (DE3) cells (Invitrogen) were transformed with vectors harbouring the cmoA gene, grown in lysogeny broth containing 100 mg ml 21 ampicillin at 37 uC and induced with 0.5 mM isopropylthiogalactoside (IPTG) at an D 600 nm of approximately 1. Cells were incubated overnight at 25 uC and collected by centrifugation. Cell pellets were resuspended with Bugbuster (Novagen) at room temperature (20 to 25 uC) for 30 min, the lysates were centrifuged at 41,400g for 30 min, and the supernatants were applied to Ni-agarose (Qiagene) columns pre-equilibrated with buffer A (20 mM HEPES, pH 7.5, and 150 mM KCl). The recombinant protein was eluted with 150 mM imidazole in buffer A and purified further by size-exclusion chromatography on a HiLoad Superdex 200 column (GE) equilibrated with buffer A. Final purity was over 95% as verified by SDS-PAGE (SDS-polyacrylamide gel electrophoresis) analysis. For the measurement of D 280 nm of the purified CmoA, the enzyme was denatured to separate SAM or Cx-SAM from the protein using multiple rounds of mixing with 8 M guanidine chloride solution followed by spin filtration. An extinction coefficient of e 280 5 18.7 cm 21 mM 21 was used to calculate the yield of the nucleoside-free CmoA as calculated from the amino acid sequence. The cmoB gene was amplified from genomic DNA of E. coli BL21 by PCR and cloned into LIC-pET30a (Novagen). The purification of E. coli CmoB was identical to that of CmoA, except for the use of kanamycin as the selectable marker. In addition, the affinity tag was removed by thrombin (Novagen) cleavage after elution of the recombinant CmoB from the Ni-agarose resin. The yield was quantified using an extinction coefficient of e 280 5 72.5cm 21 mM 21 , as calculated from the amino acid sequence.
The Asp89Leu mutant of CmoA was generated by QuickChange (Stratagene) with primers 59-TTGCAAAATTATTGCCATCCTCAACTCCCCGGCGATG ATT-39 and 59-AATCATCGCCGGGGAGTTGAGGATGGCAATAATTTTG CAA-39, and the plasmid of the wild-type CmoA as the template for PCR. Purification of the Asp89Leu mutant was similar to that of the wild type described above; some purifications included the addition of anion exchange and gelfiltration chromatography steps. For anion exchange separation, a MonoQ column (GE) was equilibrated with Buffer A (20 mM Tris-HCl, pH 8.5, and 150 mM KCl) and a 1-ml sample was loaded. A linear gradient of Buffer B (20 mM Tris-HCl, pH 8.5, and 1 M NaCl) was used to elute bound protein. Wild-type CmoA eluted as a single peak on MonoQ, whereas the Asp89Leu mutant showed two peaks. Eluted proteins were analysed by SDS-PAGE, pooled, concentrated and loaded on a Superdex75 column (GE) equilibrated with Buffer A. Crystallization and structural determination of CmoA. Purified CmoA was crystallized using the method of sitting drop vapour diffusion at 21 uC by mixing 1 ml of the protein with 1 ml of reservoir solution (0.2 M Li 2 SO 4 , 0.1 M Bis-Tris:HCl (HCl used to adjust the pH of the buffer), pH 5.5, and 25% PEG3350) and equilibrating over 0.1 ml of reservoir solution. X-ray data were collected on an ADSC QUANTUM 315 CCD detector at the National Synchotron Light Source (NSLS) beam line X29A and processed with HKL3000 (ref. 20) . Diffraction data from CmoA crystals were collected at 100 K, and at a wavelength (l) of 0.9790 Å , which were consistent with space group, P2 1 2 1 2 (a 5 65.32 Å , b 5 78.68 Å , c 5 92.37 Å ), with two molecules per asymmetric unit. Molecular replacement was carried out using the structure of H. influenzae YecO (PDB code 1IM8) as the search model with MOLREP 21 . Subsequent model building and refinement were performed with Coot 22 and REFMAC5 23 . The final model was refined to 1.50 Å with R values of R work 5 0.17 and R free 5 0.20 (Supplementary Table 1 ). All residues are in energetically allowed regions of the Ramachandran plot. Time-course assay of Cx-SAM production. The time-dependent formation of carboxyl-SAM was monitored using [ 14 C-methyl]-SAM with either prephenate or chorismate. The assay mixture contains 20 mM sodium phosphate, pH 6.8, 0.2 mM [ 14 C-methyl]-SAM (Perkin Elmer), and either 0.2 mM chorismate or prephenate. The assay was initiated by adding purified 2 mM CmoA to the assay mixture, with a total volume of 20 ml. A 2-ml aliquot was withdrawn periodically and mixed with an equal volume of 0.1 M HCl to quench the reaction, then 1 ml was spotted onto a thin layer chromatography (TLC) plate. The TLC was developed with buffer composed of 79% ammonium sulphate, 19% iso-propanol and 2% sodium acetate, pH 6.0. The plate was air-dried and exposed to a phosphor screen imager (GE) for 2 days. The image plate was scanned using a Molecular Dynamics Storm 860 PhosphorImager System with ImageQuant software. Time-course assay of phenylpyruvate production. Phenylpyruvate formation was monitored at a wavelength of 320 nm as described previously 24 . The assay mixture contained 20 mM sodium phosphate, pH 6.8, and 0.2 mM prephenate, with or without 0.2 mM SAM in a total volume of 0.5 ml. The reaction was initiated by adding 2 mM CmoA to the assay solution. A 70-ml aliquot of the reaction mixture was withdrawn periodically and added to 30 ml of 5 M NaOH. The absorbance at a wavelength of 320 nm was measured and the net D 320 nm was recorded by subtracting residual absorbance arising from contaminating phenylpyruvate. The net absorbance was converted to the concentration of phenylpyruvate using a standard curve prepared with commercially obtained phenylpyruvate (Sigma-Aldrich). Non-enzymatic turnover of prephenate to phenylpyruvate was measured with a sample composed of 20 mM sodium phosphate, pH 6.8, 0.2 mM prephenate, and 0.2 mM SAM in 0.5 ml, without the addition of the enzyme. Verification of Cx-SAM co-purified with recombinant CmoA by LC-MS. A 10-ml recombinant protein solution (10 mg ml 21 ) was diluted with 10 ml water and then with 190 ml of methanol. The mixture was centrifuged at room temperature for 10 min (16,000g), and the supernatant was used for the analysis. For each injection, an 80-ml aliquot was subjected to LC-MS analysis (Agilent 1200 HPLC coupled with Agilent 6210 AccurateMass electronspray mass spectrometer; ESI positive ion mode detection, 4 GHz, m/z range from 50 to 1,200; Phenomenex Luna NH2 column, bead size of 5 mm, pore size of 100 Å , 150 3 2 mm) using a gradient system described in the literature 25 . Data were analysed using the Agilent Mass Hunter software package. Mass-spectroscopy analysis of CmoA assay. Prephenate (10 mM; or 10 mM chorismate initially) was incubated with 10 mM SAM and 10 mM CmoA in a total of 0.5 ml solution at room temperature overnight. An aliquot of 10 ml of the reaction mixture was mixed with 100 ml methanol, which was then infused into a 12T Agilent IonSpec FT-ICR-MS (Agilent Technologies). Cx-SAM (m/z 5 443.1373) was monitored in positive mode, and phenylpyruvate (m/z 5 163.0404) was monitored in negative mode. The Agilent 12T QFT-ICR routinely provides better than 5 p.p.m. mass accuracy with external calibration. Solvent isotope exchange of deuterated SAM. The assay solution was prepared by mixing 10 mM Tris, pH 8.0, 0.5 mM [ 2 H 3 -methyl] SAM (CDNisotope), 0.5 mM prephenate and 10 mM CmoA in 0.5 ml solution. The reaction was incubated for 4 h at room temperature and was quenched by filtering the enzyme with a spin column (molecular-weight cut-off (MWCO), 10 kilodaltons (kD)). The sample was then analysed by mass spectrometry as described above. To examine whether solvent proton exchange at S-methyl of SAM is prephenate-dependent in manner, a sample without prephenate was prepared and analysed in an identical fashion. Assay of CmoB reaction. Carboxymethyltransfer activity of CmoB was examined with a solution containing 50 mM Tris, pH 8.0, 4 mM MgCl 2 , 1 mM prephenate, 1 mM SAM, 1 mM CmoA and total RNA extracted from cmoB-mutant E. coli cells as described before 16 , or purified tRNAs 2 ; the total volume of the assay was 50 ml. The reaction was initiated by adding 6 mM CmoB and incubated at the room temperature for 2 h. One unit of P1 nuclease (US Biological) was added to the assay solution and incubated at 65 uC for 1 h to convert polynucleotides into 59nucleotide monophosphates. The P1 nuclease-treated sample was mixed with 100 ml methanol and vortexed before centrifugation at 16,000g for 2 min. An aliquot of supernatant was injected to a 12T Agilent IonSpec FT-ICR-MS and analysed in negative mode. Computational ligand docking. To create a model of the substrate prephenate bound to CmoA, we first removed the carboxylate group from the product Cx-SAM to create SAM in the CmoA catalytic site. The resulting complex was subjected to a protein preparation protocol, during which hydrogen atoms were added, protonation states of His residues were examined and adjusted if necessary, side-chains of Thr, Tyr and Asn residues were optimized for hydrogen bonding interactions, and the entire structure was finally energy-minimized such that heavy atom positions remained within 0.3 Å of the starting coordinates.
Initial attempts to dock the substrate prephenate to this resulting model failed owing to inadequate space for the ligand. We proposed that charged residues in the binding site required conformational changes to accommodate the ligand. Specifically, in the Cx-SAM-bound structure, Arg 199 formed a salt-bridge interaction with the carboxylate group of Cx-SAM (Fig. 2c) , and other charged residues in the active site such as Lys 165 and Glu 203 either pointed towards the solvent or blocked portions of the active site. Therefore, we used an induced-fit docking procedure, in which side chains of residues that are within 5 Å of the docked prephenate pose were treated as conformationally flexible 26 . Induced-fit docking uses a combination of a molecular-mechanics energy function and an empirical scoring function-based energy to rank the ligand poses. We re-ranked the induced fit docking poses using a molecular-mechanics-based energy function that has been used successfully in many applications of metabolite docking. The lowest energy binding pose identified using this technique is shown in Fig. 2d . Thermal stability of wild-type and Asp89Leu mutant CmoA. The fluorescencemonitored thermal denaturation of wild-type and mutant CmoA was carried out using a 7900HT RT-PCR system (Applied Biosystems). In brief, 20 ml of each protein at 10 mM concentration was mixed with 0.5 ml of 2003 Sypro orange solution and pipetted into separate wells of a 384-well PCR plate. After centrifugation to remove air bubbles, the plate is loaded into the PCR machine and the temperature ramped from 20 to 99 uC, in 1-uC increments with a dwell time of 6 s.
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The negative first derivative of the fluorescence change (2dRFU/dT) for each protein is plotted against temperature, and the melting temperature is defined as the minimum in the 2dRFU/dT curve. The wild type from MonoQ exhibited a melting temperature (T m ) of 55.6 6 0.1 uC, whereas the two Asp89Leu mutant fractions had T m that were 2 to 3 uC lower. The behaviour of the wild-type and mutant species show that they are folded under the conditions (that is, temperature) used in in vitro activity assays; the lack of activity exhibited by the Asp89Leu mutant is thus the consequence of a catalytic defect and not due to issues related to thermodynamic stability. Chemical synthesis of Cx-SAM. S-Adenosyl-L-homocysteine (SAH; 3 mg) was dissolved in 0.5 ml of 150 mM ammonium bicarbonate. To this solution, 2-iodoacetatic acid (100 mg) was added. The mixture was incubated at 37 uC for 12 h with constant agitation. The progress of the reaction was monitored by TLC (SiO 2 ) using a solvent system composed of methanol:aqueous 1.5 N ammonium bicarbonate (10:1 vol/vol). Retardation factor (R f ) 5 0.6 and 0.3 for SAH and Cx-SAM, respectively. After the reaction was completed, 12 ml methanol was added and the mixture was incubated at 4 uC overnight. Precipitates were collected by centrifugation at 4 uC (2,000g for 30 min), washed twice with ice-cold methanol and dissolved in 0.10 ml deionized water. The product was purified using hydrophilic interaction chromatography (HILIC) as described above. Concentration of Cx-SAM was determined spectroscopically, assuming an extinction coefficient of SAM (e 260 5 15.4 cm 21 mM 21 ). Assay of non-enzymatic formation of prephenate from chorismate. The rate of conversion from chorismate to prephenate in the absence of CmoA was measured in vitro 24 . The assay solution contained 10 mM sodium phosphate (pH 6.8), 0.2 mM SAM, and 0.2 mM chorismate, in 0.5 ml. An aliquot of 80 ml was withdrawn periodically and added to 5 mL of 4.5 M HCl. The mixture was then incubated at 37 uC for 15 min and combined with 15 ml of 12 M NaOH before the absorbance at 320 nm was measured to determine phenylpyruvate. NMR analysis of the CmoA assay mixture. To define the nature of prephenatederived product subsequent to donation of the carboxylate, the in vitro assay was scaled up using 0.5 mM prephenate, 0.5 mM SAM, and 10 mM CmoA, in a total volume of 10 ml, to maximize the yield of products for NMR analysis. The reaction was incubated at room temperature for 8 h, and the enzyme was filtered using a spin column (MWCO, 10 kD) before lyophilization. The lyophilized sample was dissolved in 0.6 ml D 2 O (Cambridge Isotope Laboratory) and 1 H-resonance data was collected with a Bruker DRX-300 NMR spectrometer. Partitioning of the ylide intermediate. The pH-dependent ylide partitioning assay was carried out with 0.2 mM prephenate, 0.05 mM [ 2 H 3 -methyl] SAM in either 10 mM ammonium acetate, pH 7.3, or 10 mM ammonium bicarbonate, pH 8.5. The assay was initiated by adding 2 mM CmoA, with incubation at room temperature for 2 h before analysis with mass spectrometry as described below. The total amount of [ 2 H 3 -methyl]-and [ 2 H 2 1 H-methyl]-SAM remaining after the reaction was determined by adding a known amount of unlabelled SAM to the assay mixture as an internal standard. The concentration of Cx-SAM was determined by subtracting the remaining SAM after the reaction from the initial quantity added. The amount of solvent exchanged ( 
